|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
University of Washington National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
|---|---|
| Information provided by: | University of Washington |
| ClinicalTrials.gov Identifier: | NCT00642070 |
Purpose
This study is being done to identify those elements of the immune response that my predispose a woman to recurrent urinary tract infection. We suspect that lesser effectiveness of certain components of the host response will lead to recurrent urinary tract infection. We will also evaluate the role that the bladder reservoir may play in recurrent urinary tract infection.
| Condition |
|---|
|
Urinary Tract Infection |
| Study Type: | Observational |
| Study Design: | Case-Only, Prospective |
| Official Title: | Host Response to Urinary Tract Infection in Women |
whole blood,serum, urine
| Estimated Enrollment: | 350 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Host
Women with current symptoms of a urinary tract infection
|
Procedures subjects will undergo once they have read and signed the consent are:
Questions about their medical and sexual history and current symptoms of urinary tract infection. They will be asked to provide a clean catch urine sample. We will collect periurethral, vaginal and rectal swabs. Blood will collected. They will be given a diary to take home and record all episodes of sexual intercourse, contraceptive use, vaginal and urinary symptoms and medication use.
They will be given standard treatment for the current urinary tract infection. Follow-up visits will be scheduled 2 weeks,one month,two month and three month after initial visit.
Eligibility| Ages Eligible for Study: | 18 Years to 49 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Women between the ages of 18-49 with symptoms of a urinary tract infection for fewer than 7 days
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Niki DeShaw, Coord | 206-685-1048 | ndeshaw@u.washington.edu |
| Contact: Ellen Cassen, ARNP | 206-685-1048 | ecassen@u.washington.edu |
| United States, Washington | |
| University of Washington/Hall Health Primary Care Center | Recruiting |
| Seattle, Washington, United States, 98195 | |
| Principal Investigator: Walter E Stamm, M.D. | |
| Principal Investigator: | Walter E Stamm, M.D. | University of Washington |
More Information
| Responsible Party: | University of Washington ( Walter E. Stamm, MD ) |
| Study ID Numbers: | 31467-D, NIDDK 1 P50 AR049475-06;, 06-4836-D |
| Study First Received: | March 18, 2008 |
| Last Updated: | March 3, 2009 |
| ClinicalTrials.gov Identifier: | NCT00642070 History of Changes |
| Health Authority: | United States: Institutional Review Board |
|
Current symptoms of urinary tract infection |
|
Urologic Diseases Urinary Tract Infections |
|
Communicable Diseases Urologic Diseases Urinary Tract Infections Infection |
